Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

The conundrum of missing data vs. inter-rater variability.

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 ...

The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

A researcher in the IU Luddy School of Informatics, Computing and Engineering in Indianapolis is leading efforts to develop ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

A Manchester medtech company has secured new funding to continue scaling its reusable digital device that can track whether ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of additional years of healthy life globally. Some examples of disease areas in which ...